Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines

Bibliographic Details
Main Authors: Hlobilková, A. (Author), Bouchal, J. (Author), Knillová, J. (Author), Strnad, M. (Author), Kolář, Zdeněk, 1953- (Author)
Format: Article
Language:English